XIRESTOMIG

UNII:	Q2C2VG7V4N
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	XIRESTOMIG
GSRS Full Record:	Q2C2VG7V4N i

2756879-35-1
ATG-101
ATG101
Immunoglobulin G1 [301-alanine], bispecific, anti-(programmed death-ligand 1) (human monoclonal ATG-101 γ1-chain) fusion protein with peptide linker (GGGGS)3 fusion protein with immunoglobulin anti-(human tumor necrosis factor receptor TNFRSF9) (human single-chain variable fragment VH-(GGGGS)3-VL), disulfide with human monoclonal ATG-101 λ-chain, dimer
Xirestomig
Xirestomig [WHO-DD]
immunoglobulin G1-scFv_L2 dimer, anti-[Homo sapiens CD274 (programmed cell death 1 ligand 1, PDL1, PD-L1,B7 homolog 1, B7H1, B7-H1, PDCD1LG1) and anti-[Homo sapiens TNFRSF9 (TNF receptor superfamily member 9,4-1BB, T cell antigen ILA, CD137)], Homo sapiens monoclonal antibody, bispecific
xirestomig [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

XIRESTOMIG

Synonyms and Mappings

Resources